Literature DB >> 3210049

Progressive multifocal leucoencephalopathy and viral antibody titres.

R S Knight1, N M Hyman, S D Gardner, P E Gibson, M M Esiri, C P Warlow.   

Abstract

Progressive multifocal leucoencephalopathy (PML) is caused by a papovavirus but serum antibody titres are generally considered unhelpful in clinical diagnosis because antibodies to the commonest causal agent (JC virus) are frequently found in normal adults. There is little published information about CSF titres but usually they have not been useful. Two cases of PML, confirmed by autopsy, are described where CSF antibody to JC virus was measured. In one case the JC antibody titre was significantly higher in the CSF than the serum and we suggest that this finding is diagnostically useful. In this case there was a transient stabilization of the disease following treatment with cytarabine with a change in antibody titres suggestive of reduced viral replication in the central nervous system and a host response to the infection. In the other case, which was untreated, rising serum antibody levels indicated active infection with a host response.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3210049     DOI: 10.1007/bf00314247

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  28 in total

1.  Progressive multifocal leucoencephalopathy: remission with cytarabine.

Authors:  P J Marriott; M D O'Brien; I C Mackenzie; I Janota
Journal:  J Neurol Neurosurg Psychiatry       Date:  1975-03       Impact factor: 10.154

2.  Multiple central nervous system infections in progressive multifocal leukoencephalopathy.

Authors:  T Mathews; H Wisotzkey; J Moossy
Journal:  Neurology       Date:  1976-01       Impact factor: 9.910

3.  Adenine arabinoside in the treatment of progressive multifocal leukoencephalopathy: use of virus-containing cells in the urine to assess response to therapy.

Authors:  K H Rand; K P Johnson; L J Rubinstein; J S Wolinsky; J B Penney; D L Walker; B L Padgett; T C Merigan
Journal:  Ann Neurol       Date:  1977-05       Impact factor: 10.422

4.  Isolation of virus related to SV40 from patients with progressive multifocal leukoencephalopathy.

Authors:  L P Weiner; R M Herndon; O Narayan; R T Johnson; K Shah; L J Rubinstein; T J Preziosi; F K Conley
Journal:  N Engl J Med       Date:  1972-02-24       Impact factor: 91.245

5.  New human papovavirus (B.K.) isolated from urine after renal transplantation.

Authors:  S D Gardner; A M Field; D V Coleman; B Hulme
Journal:  Lancet       Date:  1971-06-19       Impact factor: 79.321

6.  Primary progressive multifocal leukoencephalopathy. A case report.

Authors:  C F Bolton; B Rozdilsky
Journal:  Neurology       Date:  1971-01       Impact factor: 9.910

7.  Progressive multifocal leukoencephalopathy: failure of cytarabine therapy.

Authors:  C R Smith; A A Sima; I E Salit; F Gentili
Journal:  Neurology       Date:  1982-02       Impact factor: 9.910

8.  Is progressive multifocal leukoencephalopathy associated with intrathecal IgG synthesis?

Authors:  P Mazzarello; M Poloni; M Ceroni; R Scelsi
Journal:  J Neuroimmunol       Date:  1985-12       Impact factor: 3.478

9.  Progressive multifocal leukoencephalopathy: immunofluorescent demonstration of simian virus 40 antigen in CSF cells and response to cytarabine therapy.

Authors:  A C Peters; J Versteeg; G T Bots; W Boogerd; G J Vielvoye
Journal:  Arch Neurol       Date:  1980-08

10.  The association of progressive multifocal leukoencephalopathy and sarcoidosis.

Authors:  M A Rosenbloom; D F Uphoff
Journal:  Chest       Date:  1983-03       Impact factor: 9.410

View more
  5 in total

Review 1.  Convicting a human tumor virus: guilt by association?

Authors:  J A Blaho; S A Aaronson
Journal:  Proc Natl Acad Sci U S A       Date:  1999-07-06       Impact factor: 11.205

Review 2.  Progressive multifocal leukoencephalopathy in individuals with minimal or occult immunosuppression.

Authors:  Sarah Gheuens; Gerald Pierone; Patrick Peeters; Igor J Koralnik
Journal:  J Neurol Neurosurg Psychiatry       Date:  2009-10-14       Impact factor: 10.154

Review 3.  Progressive multifocal leukoencephalopathy in AIDS: a clinicopathologic study and review of the literature.

Authors:  R W von Einsiedel; T D Fife; A J Aksamit; M E Cornford; D L Secor; U Tomiyasu; H H Itabashi; H V Vinters
Journal:  J Neurol       Date:  1993-07       Impact factor: 4.849

4.  Detection of JC virus DNA in human tonsil tissue: evidence for site of initial viral infection.

Authors:  M C Monaco; P N Jensen; J Hou; L C Durham; E O Major
Journal:  J Virol       Date:  1998-12       Impact factor: 5.103

Review 5.  Pathogenesis and molecular biology of progressive multifocal leukoencephalopathy, the JC virus-induced demyelinating disease of the human brain.

Authors:  E O Major; K Amemiya; C S Tornatore; S A Houff; J R Berger
Journal:  Clin Microbiol Rev       Date:  1992-01       Impact factor: 26.132

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.